Bond.az White LogoBond.az Black Logo

TD Cowen reiterates Buy on Microsoft, cites Azure growth

TD Cowen reiterates Buy on Microsoft stock, citing Azure growth and Copilot adoption. Bond.az provides analysis on Microsoft's AI strategy and financial outlook.

Samuel Nguyen
BySamuel Nguyen- Senior Editor
|
0

TD Cowen reiterated a Buy rating and $540 price target on Microsoft (NASDAQ:MSFT). The firm hosted Mary Grekstas from investor relations for virtual meetings.

The stock trades at $409.43, down 15% year-to-date. Bond.az analysis suggests the company remains undervalued. With a $3.04 trillion market cap and P/E of 24.4, Microsoft remains a key software player despite headwinds.

Microsoft expects capacity constraints through at least end-2026 but efficiency gains have freed up compute. More capacity is allocated to Azure workloads, supporting growth in H2 2026. Ramping 2GW at Fairwater and building capacity for Anthropic after a $30B commitment are new AI drivers.

Copilot adoption inflected last quarter due to accelerated innovation and improved go-to-market. Microsoft expects more net subscriber additions in Q2 vs Q1's ~5 million. New drivers include E7 bundle and Copilot Cowork.

For GitHub Copilot, new per-user plus consumption pricing aims to expand TAM and capture value from agentic usage. AI workloads continue driving consumption of Microsoft services.

Dynamics 365 bookings commentary noted softer growth in Q2 guidance as customers shift to seats-plus-agents. Dynamics 365 consumption revenue can fall into M365 or Azure.

In other news, Microsoft added Carmine Di Sibio to its board. LinkedIn plans to cut ~5% of workforce. OpenAI revenue-sharing capped at $38B. US Commerce Dept removed AI testing details from website.

More News
2026-06-01 12:02
|
743

Legend Biotech Buy Rating Reiterated

H.C. Wainwright reiterated its Buy rating for Legend Biotech with a $50 target. Revenue up 56% over twelve months.

0
2026-06-01 12:01
|
475

Cogent Stock Price Target Raised to $55

Cogent Biosciences PEAK trial: combination therapy shows 45.6% response rate, 16.5 months PFS, FDA accepts NDA. H.C. Wainwright raises price target to $55.

0
2026-06-01 12:00
|
841

H.C. Wainwright Reaffirms Mineralys Buy

H.C. Wainwright reiterated a Buy rating on Mineralys Therapeutics with a $56 price target after positive trial data.

0
2026-06-01 10:33
|
714

Goldman Sachs Upgrades Marriott Vacations Stock

Goldman Sachs upgrades Marriott Vacations stock to Buy, price target $100. Execution potential drives earnings upside.

0
2026-06-01 10:32
|
730

Goldman Sachs Upgrades Travel + Leisure Stock to Buy

Goldman Sachs upgraded Travel + Leisure stock to Buy with a $85 price target. Learn about the company's financials, dividends, and market outlook.

0
2026-06-01 10:32
|
238

Canaccord Initiates Rare Earths Americas with Buy

Canaccord Genuity initiates Rare Earths Americas with a buy rating and $25 target. Stock at $21.85, offering 14% upside potential.

0
2026-06-01 10:30
|
651

BofA Raises Icon Stock Target to $125 on Bookings

BofA Securities raised Icon plc price target to $125, maintains Underperform. Improved booking trends and Q4 results drive revision.

0
2026-06-01 10:03
|
748

RBC Capital: Sprouts faces Kroger risk

RBC Capital keeps Sprouts rating but sees risks from Kroger price cuts. Analysis and outlook on Bond.az.

0
2026-06-01 09:02
|
551

CLSA Rates Chagee Hold on Margins

CLSA initiated Chagee Holdings with Hold rating and $10 target. Bond.az analysis reveals stock may be undervalued. Read more.

0
2026-06-01 08:31
|
594

Barclays Downgrades Sensata Stock on Valuation

Barclays downgrades Sensata stock to Equalweight on valuation concerns, but raises price target to $53. Stock surged 92% in past year.

0
2026-06-01 08:05
|
946

UBS Initiates Veritone Coverage with Neutral

UBS initiated coverage on Veritone with a Neutral rating and $2.50 price target. The AI company is better positioned for growth after transformation.

0
2026-06-01 08:02
|
892

JMP Securities Initiates Microsoft with Outperform on AI Strategy

JMP Securities initiates Microsoft with Market Outperform rating and $550 target on AI strategy. Revenue growth expected to reach 17% in FY2026.

0
...
TD Cowen reiterates Buy on Microsoft, cites Azure growth | Bond.az